The effects of activated protein C and prostacyclin on arterial oxygenation and protein leakage in the lung and the gut under endotoxaemia in the rat

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 3, 2008, Pages 381-387

  Dubniks, M ^a,b   GrAnde P O ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Activated protein C; Endotoxin; LPS; Microcirculation; Oxygenation; Prostacyclin; Sepsis; SIRS

Indexed keywords

ALBUMIN; ALBUMIN I 125; BACTERIUM LIPOPOLYSACCHARIDE; DROTRECOGIN; PROSTACYCLIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTERIAL BLOOD; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD SAMPLING; CAPILLARY; CAPILLARY LEAK SYNDROME; CONTINUOUS INFUSION; DRUG EFFICACY; DRY WEIGHT; ENDOTOXEMIA; ESCHERICHIA COLI; INTESTINE CAPILLARY; LUNG CAPILLARY; LUNG WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RAT; VENOUS BLOOD;

ALBUMINS; ANIMALS; CAPILLARY LEAK SYNDROME; ENDOTOXINS; EPOPROSTENOL; INFLAMMATION; INTESTINAL DISEASES; LUNG DISEASES; MALE; OXYGEN; PROTEIN C; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 38849198466     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2007.01532.x     Document Type: Article

References (45)

1. Bateman RM, Sharpe MD, Ellis CG. Bench-to-bedside review: microvascular dysfunction in sepsis - hemodynamics, oxygen transport, and nitric oxide. Crit Care 2003 7 : 359 73.
2. Aird WC. The role of endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003 101 : 3765 77.
3. Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation 2004 109 : 2698 704.
4. Christ F, Gamble J, Gartside IB et al. Increased microvascular water permeability in patients with septic shock, assessed with venous congestion plethysmography (VCP). Intensive Care Med 1998 24 : 18 27.
5. Fleck A, Raines G, Hawker F et al. Increased microvascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1985 1 : 781 4.
6. De Backer D, Creteur J, Preiser JC et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002 166 : 98 104.
7. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005 9 : (Suppl. 4) : 13 19. Review.
8. Sakr Y, Dubois MJ, De Backer D et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004 32 : 1825 31.
9. Fink MP. Gastrointestinal mucosal injury in experimental models of shock, trauma and sepsis. Crit Care Med 1991 19 : 627 41.
10. Marlar RA, Kleiss AJ, Griffin JH. Human protein C: inactivation of factors V and VIII in plasma by the activated molecule. Ann NY Acad Sci 1981 370 : 303 10.
11. Gruber A, Hanson SR, Kelly AB et al. Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation 1990 82 : 578 85.
12. Sakata Y, Curriden S, Lawrence D et al. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci USA 1985 82 : 1121 5.
13. van Hinsbergh VW, Bertina RM, van Wijngaardern A et al. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood 1985 65 : 444 51.
14. Esmon CT. The anticoagulant and anti-inflammatory roles of the protein C anticoagulant pathway. J Autoimmun 2000 15 : 113 6.
15. Okajima K. Prevention of endothelial cell injury by activated protein C: the molecular mechanisms and therapeutic implications. Curr Vasc Pharmacol 2004 2 : 125 33.
16. Iba T, Kidokoro A, Fukunaga M et al. Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model. Crit Care Med 2005 33 : 368 72.
17. Lehmann C, Meissner K, knock A et al. Activated protein C improves intestinal microcirculation in experimental endotoxemia in the rat. Crit Care 2006 10 : R157.
18. Brueckmann M, Horn S, Lang S et al. Recombinant human activated protein C upregulates cyclooxygenase-2 expression in endothelial cells via binding to endothelial cell protein C receptor and activation of protease-activated receptor-I. Thromb Haemost 2005 93 : 743 50.
19. Fisher CJ, Yan SB. Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 2000 28 : S49 56.
20. Yan BS, Helterbrand JD, Hartman DL et al. Low levels of protein C are associated with poor outcome in severe sepsis. Chest 2001 120 : 915 22.
21. Faust SN, Levin M, Harrison OB et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001 345 : 408 16.
22. Ware LB, Fang X, Matthay MA. Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol 2003 285 : L514 21.
23. Lignell A, Siegbahn A, Stridsberg M et al. Low utilization of unactivated protein C in a patient with meningococcal septic shock and disseminated intravascular coagulation. Acta Anaesthesiol Scand 2003 47 : 897 900.
24. Taylor FB Jr., Chang A, Esmon CT et al. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987 79 : 918 25.
25. Bernard GR, Vincent JL, Laterre PF et al. Recombinant human protein C worldwide evaluation in severe sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001 344 : 699 709.
26. Gårdlund B. Activated protein C (Xigris) treatment in sepsis: a drug in trouble. Acta Anaesthesiol Scand 2006 50 : 907 10.
27. Ubatuba FB, Moncada S, Vane JR. The effect of prostacyclin (PGI2) on platelet behaviour. Thrombus formation in vivo and bleeding time. Thromb Haemost 1979 41 : 425 35.
28. Jones G, Hurley JV. The effects of prostacyclin on the adhesion of leucocytes to injured vascular endothelium. J Pathol 1984 142 : 51 9.
29. Zardi EM, Zardi DM, Dobrina A et al. Prostacyclin in sepsis: a systematic review. Prostaglandins Other Lipid Mediators 2007 83 : 1 24.
30. Ditter H, Matthias FR, Voss R et al. Beneficial effects of prostacyclin in a rabbit endotoxic shock model. Thromb Res 1988 51 : 403 15.
31. Crutchley JD, Conanan LB, Que BG. Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alfa and interleukin-1-beta in human monocytic THP-1 cells. J Pharmacol Exp Therap 1994 271 : 446 51.
32. Oettinger W, Berger D, Beger HG. The clinical significance of prostaglandins and thromboxane as mediators of septic shock. Klin Wochenschr 1987 65 : 61 8.
33. Deby-Dupont G, Braun M, Lamy M et al. Thromboxane and prostacyclin release in adult respiratory distress syndrome. Intensive Care Med 1987 13 : 167 74.
34. Möller AD, Grände PO. Beneficial effects of low-dose prostacyclin on cat intestinal perfusion during endotoxemia as evaluated with microdialysis and oxygen transport variables. Crit Care Med 2001 29 : 351 8.
35. Manasia A, Kang H, Hannon E et al. Effects of the stable prostacyclin analogue iloprost on mesenteric blood flow in porcine endotoxic shock. Crit Care Med 1997 25 : 1222 7.
36. Möller AD, Grände PO. Role of prostacyclin and nitric oxide in regulation of basal microvascular hydraulic permeability in cat skeletal muscle. J Vasc Res 1999 36 : 245 52.
37. Bentzer P, Grände PO. Low-dose prostacyclin restores an increased protein permeability after trauma in cat skeletal muscle. J Trauma 2004 56 : 385 92.
38. Lehmann C, Taymoorian K, Wauer H et al. Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock. Intensive Care Med 2000 26 : 1557 60.
39. Bihari DJ, Tinker J. The therapeutic value of vasodilator prostaglandins in multiple organ failure associated with sepsis. Intensive Care Med 1988 15 : 2 7.
40. Kiefer P, Tugtekin I, Wiedeck H et al. Hepato-splanchnic metabolic effects of the stable prostacyclin analogue iloprost in patients with septic shock. Intensive Care Med 2001 27 : 1179 86.
41. Remick DG, Ward PA. Evaluation of endotoxin models for the study of sepsis. Shock 2005 24 (Suppl. 1) : 7 11.
42. Drazenovic R, Samsel RW, Wylam ME et al. Regulation of perfused capillary density in canine intestinal mucosa during endotoxemia. J Appl Physiol 1992 72 : 259 65.
43. Chabbat J, Taby O, Toully V et al. The behavior of human activated protein C in the plasma of different laboratory animals. Thromb Haemost 1991 65 : A1814.
44. Favory R, Lancel S, Marechal X et al. Cardiovascular protective role for activated protein C during endotoxemia in rats. Intensive Care Med 2006 32 : 899 905.
45. Eichelbronner O, Reinelt H, Wiedeck H et al. Aerosolized prostacyclin and inhaled nitric oxide in septic shock - different effects on splanchnic oxygenation? Intensive Care Med 1996 22 : 880 7.